Nuzenio

Pharma Direct

Pharma Direct entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

GDRX: Pharma Direct and subscriptions drove Q2 outperformance, leading to raised 2026 guidance - TradingViewTradingView · Thu, 06 Aug 2026 14:00:44 GMTGDRX: Pharma Direct and subscription growth drove raised 2026 guidance despite lower transactions - TradingViewTradingView · Wed, 05 Aug 2026 20:33:39 GMTGDRX: Revenue declines as Pharma Direct and subscriptions grow, but legal and market risks remain high - TradingViewTradingView · Wed, 05 Aug 2026 20:21:25 GMTGoodRx Holdings, Inc. 2026: Revenue $200.41M, EPS $0.02— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:11:00 GMT

Timeline

Thu, 06 Aug 2026 14:00:44 GMTGDRX: Pharma Direct and subscriptions drove Q2 outperformance, leading to raised 2026 guidance - TradingView
Wed, 05 Aug 2026 20:33:39 GMTGDRX: Pharma Direct and subscription growth drove raised 2026 guidance despite lower transactions - TradingView
Wed, 05 Aug 2026 20:21:25 GMTGDRX: Revenue declines as Pharma Direct and subscriptions grow, but legal and market risks remain high - TradingView
Wed, 05 Aug 2026 20:11:00 GMTGoodRx Holdings, Inc. 2026: Revenue $200.41M, EPS $0.02— 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pharma Direct.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.